1-(1-Cyclohexanecarbonyl-1,2,3,4-tetrahydroquinolin-2-ylmethyl)-2-(pyridin-3-yl)-pyrrolidine | 511233-86-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 1-(1-Cyclohexanecarbonyl-1,2,3,4-tetrahydroquinolin-2-ylmethyl)-2-(pyridin-3-yl)-pyrrolidine
• 英文别名: cyclohexyl-[2-[(2-pyridin-3-ylpyrrolidin-1-yl)methyl]-3,4-dihydro-2H-quinolin-1-yl]methanone
• CAS: 511233-86-6
• 化学式: C₂₆H₃₃N₃O
• 分子量: 403.568
• InChiKey: NHELCQJCDBWRDI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.8
• 重原子数：
  30
• 可旋转键数：
  4
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.54
• 拓扑面积：
  36.4
• 氢给体数：
  0
• 氢受体数：
  3

文献信息

• Novel N-acylated heterocycles
  申请人：Recordati S.A.

  公开号：US20030162777A1

  公开（公告）日：2003-08-28

  Described are compositions comprising a muscarinic receptor antagonist and an N-acylated heterocycle derivative having affinity for serotonergic receptors, and enantiomers, diastereoisomers, N-oxides, polymorphs, solvates and pharmaceutically acceptable salts thereof. The combination of a muscarinic receptor antagonist and an N-acylated heterocycle, or an enantiomer, diastereoisomer, N-oxide, polymorph, solvate or pharmaceutically acceptable salt thereof, is useful in the treatment of patients with neuromuscular dysfunction of the lower urinary tract and diseases related to 5-HT 1A receptors.

  描述了包含一种肌氨酸受体拮抗剂和一种对5-HT 1A 受体具有亲和力的N-酰化杂环衍生物的组合物，以及它们的对映体、二对映体、N-氧化物、多型体、溶剂合物和药用可接受盐。肌氨酸受体拮抗剂和N-酰化杂环，或其对映体、二对映体、N-氧化物、多型体、溶剂合物或药用可接受盐的组合，在治疗患有下尿路神经肌肉功能障碍和与5-HT 1A 受体相关疾病的患者中是有用的。
• [EN] HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF DISORDERS OF THE URINARY TRACT<br/>[FR] COMPOSES HETEROCYCLIQUES UTILISES POUR TRAITER DES TROUBLES DE LA VOIE URINAIRE
  申请人：RECORDATI CHEM PHARM

  公开号：WO2003031436A1

  公开（公告）日：2003-04-17

  Compounds of formula (I) are thus useful for treating disorders of the urinary tract. In the compounds I, R1 = one or more substituents selected from H, halogen, OH, alkyl, haloalkyl, alkoxy, haloalkoxy, NO2, nitro, phenyl, substituted phenyl, heterocycle, substituted heterocycle, NR3R4(R3 and R4 being H, alkyl, acyl or alkoxycarbonyl); R2 = one or two substituents selected from H, alkyl; Y = CH2 or a bond; Q = CO, CS or SO2; A = alkyl, alkenyl, cycloalkyl, cycloalkenyl, aryl, heterocyclic, alkylamino, dialkylamino, arylamino or arylalkylamino, each of which is optionally substituted; n is 1 or 2; X = an amino moiety selected from formula (a), (b) and -N(R5)-CH2-(R5 = H, methyl, benzyl group; W = bond, N, CH, CH2, C(CN) C(OH) or C(COCH3) (when W represents a nitrogen atom or a CH, C(CN) C(OH) or C(COCH3) group, the group Z-B attaches to the W ring atom); when X is (a) or (b), Z = bond, O, S, CH2, CH2CH2, CO, CHOH, OCH2, NH, NHCO or NHCONHCH2, but when X is -N(R5)-CH2-group, Z represents a CH2CH2 or CH2O group or Z and B together represent a 2,3-dihydro-benzo[1,4]dioxin-2-yl group; and B is a monocyclic or bicyclic aryl group or a monocyclic or bicyclic heterocycle, each of which is optionally substituted.

  公式（I）的化合物因此对治疗泌尿道疾病有用。在化合物I中，R1 = H，卤素，OH，烷基，卤代烷基，烷氧基，卤代烷氧基，NO2，硝基，苯基，取代苯基，杂环，取代杂环，NR3R4（其中R3和R4为H，烷基，酰基或烷氧羰基）中的一个或多个取代基; R2 = H，烷基中的一个或两个取代基; Y = CH2或键; Q = CO，CS或SO2; A = 烷基，烯基，环烷基，环烯基，芳基，杂环，烷基氨基，二烷基氨基，芳基氨基或芳基烷基氨基，每个取代基都是可选的; n为1或2; X = 公式（a），（b）和-N（R5）- -（R5 = H，甲基，苯甲基）中选择的氨基基团; W = 键，N，CH， ，C（CN）C（OH）或C（COCH3）（当W表示氮原子或CH，C（CN）C（OH）或C（COCH3）基团时，基团Z-B附着在W环原子上）; 当X为（a）或（b）时，Z = 键，O，S， ， ，CO，CHOH，O ，NH，NHCO或NHCONH ，但当X为-N（R5）- -基团时，Z表示 或 O基团，或Z和B一起表示2,3-二氢苯并[1,4]二氧杂环-2-基团; B是单环或双环芳基或单环或双环杂环，每个取代基都是可选的。
• HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF DISORDERS OF THE URINARY TRACT
  申请人：RECORDATI S.A.CHEMICAL and PHARMACEUTICAL COMPANY

  公开号：EP1432701A1

  公开（公告）日：2004-06-30